We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $5.56B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-1.81%
1 Year Est. Return
+17.89%
3 Year Est. Return
+82.34%
5 Year Est. Return
+87.83%
10 Year Est. Return
AUM
$5.56B
AUM Growth
+$94.2M
Cap. Flow
+$295M
Cap. Flow %
5.3%
Top 10 Hldgs %
35.79%
Holding
4,002
New
389
Increased
2,051
Reduced
771
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 16.32%
2 Healthcare 6.92%
3 Financials 6.46%
4 Communication Services 5.74%
5 Consumer Discretionary 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSO icon
2601
ProShares Ultra S&P500
SSO
$7.82B
$13.3K ﹤0.01%
256
KRNT icon
2602
Kornit Digital
KRNT
$706M
$13.2K ﹤0.01%
902
+673
+294% +$9.84K
MRCY icon
2603
Mercury Systems
MRCY
$6.2B
$13.2K ﹤0.01%
181
LAND
2604
Gladstone Land Corp
LAND
$368M
$13.2K ﹤0.01%
1,293
+100
+8% +$1.08K
IPI icon
2605
Intrepid Potash
IPI
$460M
$13.2K ﹤0.01%
+308
New +$11.1K
MTH icon
2606
Meritage Homes
MTH
$4.87B
$13.2K ﹤0.01%
213
+38
+22% +$2.69K
BELFB
2607
Bel Fuse Inc Class B
BELFB
$3.88B
$13.1K ﹤0.01%
66
+37
+128% +$7.73K
GIII icon
2608
G-III Apparel Group
GIII
$1.47B
$13K ﹤0.01%
471
-1,308
-74% -$38.3K
MGRC icon
2609
McGrath RentCorp
MGRC
$2.94B
$13K ﹤0.01%
118
-1
-0.8% -$111
EETH icon
2610
ProShares Ether Strategy ETF
EETH
$54.2M
$13K ﹤0.01%
501
WCLD
2611
WisdomTree Cloud Computing Fund
WCLD
$240M
$13K ﹤0.01%
475
PTGX icon
2612
Protagonist Therapeutics
PTGX
$8.75B
$13K ﹤0.01%
123
+14
+13% +$1.24K
GDEC icon
2613
FT Vest US Equity Moderate Buffer ETF December
GDEC
$439M
$13K ﹤0.01%
+350
New +$13.2K
PSC icon
2614
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.52B
$12.9K ﹤0.01%
+225
New +$13.4K
AMPH icon
2615
Amphastar Pharmaceuticals
AMPH
$825M
$12.9K ﹤0.01%
657
+589
+866% +$14.4K
XNTK icon
2616
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$12.8K ﹤0.01%
50
COCP icon
2617
Cocrystal Pharma
COCP
$12.4M
$12.7K ﹤0.01%
12,569
SDIV icon
2618
Global X SuperDividend ETF
SDIV
$1.21B
$12.7K ﹤0.01%
502
+272
+118% +$6.91K
RWR icon
2619
State Street SPDR Dow Jones REIT ETF
RWR
$1.93B
$12.6K ﹤0.01%
125
-334
-73% -$34.4K
CRMG
2620
Leverage Shares 2X Long CRM Daily ETF
CRMG
$51.6M
$12.6K ﹤0.01%
+2,000
New +$16.4K
CLBK icon
2621
Columbia Financial
CLBK
$1.13B
$12.6K ﹤0.01%
719
-52
-7% -$894
LBRDK icon
2622
Liberty Broadband Class C
LBRDK
$4.15B
$12.6K ﹤0.01%
250
-52
-17% -$2.62K
IHF icon
2623
iShares US Healthcare Providers ETF
IHF
$1.18B
$12.6K ﹤0.01%
+300
New +$13.7K
SFL icon
2624
SFL Corp
SFL
$1.59B
$12.5K ﹤0.01%
1,162
+773
+199% +$7.48K
IPAR icon
2625
Interparfums
IPAR
$3.92B
$12.5K ﹤0.01%
138
-20
-13% -$1.9K

Similar funds

Parallel Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors deployed $295M of net new capital in Q1 2026, opening 389 new positions and adding to 2,051 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.

  • Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
  • Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
  • Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
  • Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
  • Parallel Advisors opened 389 new positions and closed 169 in Q1 2026.
  • Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.